Ravulizumab use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice

PurposeTo describe the early experience of ravulizumab use in acetylcholine receptor antibody-positive generalized myasthenia gravis (AChR+ve gMG).MethodsThis multicenter retrospective study included AChR+ve gMG patients who were treated with ravulizumab and had both pre- and post-ravulizumab myasth...

Full description

Bibliographic Details
Published in:Frontiers in Neurology
Main Authors: Nakul Katyal, Raghav Govindarajan, Neelam Goyal, Suraj Muley, Srikanth Muppidi
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-06-01
Subjects:
acetylcholine receptor antibody positive
generalized myasthenia gravis
ravulizumab
MG-ADL
complement inhibition
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2024.1378080/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2024.1378080/full

Similar Items